Share Price and Basic Stock Data
Last Updated: December 16, 2025, 1:13 am
| PEG Ratio | 3.50 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dalmia Bharat Sugar & Industries Ltd operates in the sugar sector, a space that has faced its share of ups and downs in recent years. The company’s revenue for FY 2025 stood at ₹3,746 Cr, reflecting a notable increase from ₹3,252 Cr in FY 2023. This upward trajectory is encouraging, particularly as the company recorded sales of ₹1,149 Cr in Q4 FY 2023, a substantial recovery from the lower figures seen in the previous quarters. For instance, the sales dipped to ₹579 Cr in Q2 FY 2023 but have since rebounded, suggesting that seasonal fluctuations are being managed effectively. With a market capitalization of ₹2,360 Cr and a price of ₹292 per share, the company’s valuation metrics appear attractive, especially given its P/E ratio of 7.19, which is low compared to the industry average, indicating potential undervaluation. Additionally, the company’s operational focus on expanding its production capabilities and diversifying into value-added products could further bolster revenue streams in the coming years.
Profitability and Efficiency Metrics
When examining profitability, Dalmia Bharat demonstrates a decent operating profit margin (OPM) of 9%, which has fluctuated over the last few quarters but remains competitive within the industry. In FY 2025, the operating profit rose to ₹470 Cr, compared to ₹437 Cr in FY 2023. The net profit of ₹387 Cr for FY 2025, up from ₹250 Cr in FY 2023, indicates that the company is successfully managing its costs, even though expenses have also increased to ₹3,276 Cr. The interest coverage ratio stands at a robust 10.79x, suggesting that the company comfortably meets its interest obligations. However, the cash conversion cycle of 208 days may raise eyebrows; while it has improved from previous years, it still suggests a longer duration for converting inventory into cash, which can hinder liquidity. Overall, while the profitability metrics appear solid, ongoing efficiency improvements will be crucial for enhancing the bottom line.
Balance Sheet Strength and Financial Ratios
Dalmia Bharat’s balance sheet reflects a mixed picture of strength and vulnerability. The company reported total borrowings of ₹547 Cr against reserves of ₹3,209 Cr, which demonstrates a healthy reserve-to-debt ratio. This translates to a comfortable long-term debt-to-equity ratio of 0.11, indicating prudent leverage management. However, the total debt-to-equity ratio of 0.48 suggests that the company is still reliant on debt to some extent, which could pose risks in a rising interest rate environment. The current ratio stands at 1.55, indicating that the company can cover its short-term liabilities, but the quick ratio of 0.44 hints at potential liquidity challenges when inventory is excluded. These financial ratios suggest that while Dalmia Bharat is positioned well in terms of equity, its reliance on debt financing and the liquidity challenges indicated by the quick ratio warrant close monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dalmia Bharat Sugar highlights a significant promoter holding of 74.92%, reflecting strong management control over the company. This high level of promoter ownership can be a double-edged sword; while it may instill confidence among retail investors regarding the commitment of the management, it also raises questions about the lack of diverse perspectives in strategic decisions. Foreign institutional investors (FIIs) hold a mere 0.97%, while domestic institutional investors (DIIs) are at a minimal 0.05%, indicating limited institutional interest. On the flip side, the number of public shareholders has increased to 46,427, suggesting growing retail participation. This increase could be a positive sign for liquidity and market interest. However, the low institutional stake may indicate that larger investors are cautious about the stock, possibly due to the inherent volatility in the sugar sector.
Outlook, Risks, and Final Insight
Looking ahead, Dalmia Bharat Sugar & Industries faces several opportunities and challenges. The company’s focus on expanding its production and venturing into value-added products positions it well for growth. However, the volatility in sugar prices, influenced by global supply and demand dynamics, remains a significant risk. Additionally, rising operational costs could pressure margins if not managed effectively. The extended cash conversion cycle is another concern, potentially impacting liquidity. Investors should weigh these risks against the solid financial fundamentals and the company’s strategic direction. Overall, Dalmia Bharat presents an intriguing investment case, particularly for those who can tolerate sector-related volatility. The combination of a strong balance sheet, improving profitability metrics, and the potential for revenue growth makes it a stock to watch, albeit with caution regarding the inherent risks in the sugar industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 82.0 Cr. | 11.0 | 16.7/7.02 | 293 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 78.8 Cr. | 90.2 | 132/82.0 | 20.0 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 527 Cr. | 79.4 | 124/57.3 | 308 | 145 | 1.57 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 1,433 Cr. | 165 | 208/142 | 23.5 | 105 | 1.21 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 555 Cr. | 3.88 | 12.4/3.03 | 43.9 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,767.81 Cr | 263.02 | 45.26 | 225.56 | 0.68% | 8.62% | 7.89% | 6.37 |
All Competitor Stocks of Dalmia Bharat Sugar & Industries Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 924 | 579 | 600 | 1,149 | 834 | 732 | 584 | 750 | 960 | 923 | 841 | 1,018 | 943 |
| Expenses | 815 | 572 | 488 | 941 | 715 | 666 | 474 | 631 | 849 | 854 | 744 | 823 | 857 |
| Operating Profit | 109 | 7 | 112 | 208 | 118 | 65 | 109 | 119 | 111 | 70 | 98 | 194 | 86 |
| OPM % | 12% | 1% | 19% | 18% | 14% | 9% | 19% | 16% | 12% | 8% | 12% | 19% | 9% |
| Other Income | 2 | 41 | 23 | 12 | 9 | 56 | 24 | 37 | 16 | 19 | 23 | 20 | 14 |
| Interest | 11 | 8 | 9 | 9 | 10 | 16 | 8 | 16 | 26 | 12 | 9 | 16 | 16 |
| Depreciation | 28 | 28 | 32 | 34 | 31 | 31 | 32 | 33 | 26 | 32 | 35 | 38 | 32 |
| Profit before tax | 72 | 13 | 93 | 176 | 87 | 74 | 93 | 107 | 75 | 45 | 76 | 161 | 51 |
| Tax % | 32% | 8% | 31% | 30% | 30% | 26% | 33% | 14% | 27% | -62% | 22% | -28% | 25% |
| Net Profit | 49 | 12 | 65 | 124 | 61 | 55 | 62 | 91 | 55 | 74 | 60 | 206 | 38 |
| EPS in Rs | 6.09 | 1.45 | 8.02 | 15.35 | 7.58 | 6.79 | 7.68 | 11.29 | 6.77 | 9.11 | 7.36 | 25.50 | 4.74 |
Last Updated: August 20, 2025, 11:50 am
Below is a detailed analysis of the quarterly data for Dalmia Bharat Sugar & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 943.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,018.00 Cr. (Mar 2025) to 943.00 Cr., marking a decrease of 75.00 Cr..
- For Expenses, as of Jun 2025, the value is 857.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 823.00 Cr. (Mar 2025) to 857.00 Cr., marking an increase of 34.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 108.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Mar 2025) to 9.00%, marking a decrease of 10.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 38.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 6.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 110.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -28.00% (Mar 2025) to 25.00%, marking an increase of 53.00%.
- For Net Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 168.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.74. The value appears to be declining and may need further review. It has decreased from 25.50 (Mar 2025) to 4.74, marking a decrease of 20.76.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:28 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,190 | 1,150 | 1,166 | 1,686 | 2,244 | 2,018 | 2,110 | 2,685 | 3,007 | 3,252 | 2,899 | 3,746 | 3,789 |
| Expenses | 1,083 | 1,037 | 939 | 1,307 | 2,010 | 1,781 | 1,772 | 2,213 | 2,539 | 2,815 | 2,487 | 3,276 | 3,351 |
| Operating Profit | 108 | 113 | 227 | 378 | 234 | 237 | 338 | 472 | 467 | 437 | 412 | 470 | 438 |
| OPM % | 9% | 10% | 19% | 22% | 10% | 12% | 16% | 18% | 16% | 13% | 14% | 13% | 12% |
| Other Income | 20 | 16 | 21 | 24 | 37 | 87 | 60 | 53 | 48 | 77 | 128 | 74 | 74 |
| Interest | 76 | 78 | 87 | 102 | 69 | 69 | 88 | 62 | 35 | 38 | 50 | 63 | 52 |
| Depreciation | 49 | 51 | 113 | 56 | 54 | 52 | 57 | 96 | 95 | 121 | 127 | 131 | 140 |
| Profit before tax | 3 | 0 | 47 | 244 | 148 | 204 | 252 | 368 | 386 | 355 | 363 | 350 | 321 |
| Tax % | -17% | -429% | -23% | 23% | 9% | 8% | 21% | 27% | 24% | 30% | 25% | -11% | |
| Net Profit | 3 | 1 | 58 | 187 | 134 | 187 | 198 | 270 | 295 | 250 | 272 | 387 | 328 |
| EPS in Rs | 0.37 | 0.18 | 7.22 | 23.09 | 16.58 | 23.16 | 24.48 | 33.31 | 36.51 | 30.91 | 33.68 | 47.81 | 40.59 |
| Dividend Payout % | 0% | 0% | 8% | 9% | 0% | 7% | 8% | 9% | 11% | 13% | 15% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -66.67% | 5700.00% | 222.41% | -28.34% | 39.55% | 5.88% | 36.36% | 9.26% | -15.25% | 8.80% | 42.28% |
| Change in YoY Net Profit Growth (%) | 0.00% | 5766.67% | -5477.59% | -250.76% | 67.89% | -33.67% | 30.48% | -27.10% | -24.51% | 24.05% | 33.48% |
Dalmia Bharat Sugar & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 8% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 60% |
| 5 Years: | 14% |
| 3 Years: | 10% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 2:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 445 | 442 | 495 | 1,234 | 1,433 | 1,534 | 1,592 | 2,074 | 2,343 | 2,689 | 2,916 | 3,218 | 3,209 |
| Borrowings | 812 | 931 | 1,138 | 1,214 | 776 | 1,037 | 1,277 | 958 | 819 | 454 | 1,430 | 1,044 | 547 |
| Other Liabilities | 444 | 443 | 411 | 459 | 632 | 620 | 642 | 629 | 645 | 644 | 800 | 585 | 462 |
| Total Liabilities | 1,716 | 1,833 | 2,059 | 2,923 | 2,857 | 3,207 | 3,528 | 3,677 | 3,822 | 3,803 | 5,162 | 4,863 | 4,234 |
| Fixed Assets | 767 | 746 | 752 | 1,280 | 1,293 | 1,316 | 1,353 | 1,308 | 1,531 | 1,652 | 1,847 | 1,804 | 1,600 |
| CWIP | 13 | 28 | 6 | 2 | 7 | 11 | 6 | 27 | 59 | 21 | 133 | 188 | 212 |
| Investments | 78 | 83 | 92 | 275 | 435 | 288 | 447 | 563 | 594 | 736 | 629 | 583 | 1,040 |
| Other Assets | 858 | 976 | 1,209 | 1,366 | 1,122 | 1,592 | 1,722 | 1,778 | 1,639 | 1,393 | 2,554 | 2,289 | 1,383 |
| Total Assets | 1,716 | 1,833 | 2,059 | 2,923 | 2,857 | 3,207 | 3,528 | 3,677 | 3,822 | 3,803 | 5,162 | 4,863 | 4,234 |
Below is a detailed analysis of the balance sheet data for Dalmia Bharat Sugar & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,209.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,218.00 Cr. (Mar 2025) to 3,209.00 Cr., marking a decrease of 9.00 Cr..
- For Borrowings, as of Sep 2025, the value is 547.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,044.00 Cr. (Mar 2025) to 547.00 Cr., marking a decrease of 497.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 462.00 Cr.. The value appears to be improving (decreasing). It has decreased from 585.00 Cr. (Mar 2025) to 462.00 Cr., marking a decrease of 123.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,234.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,863.00 Cr. (Mar 2025) to 4,234.00 Cr., marking a decrease of 629.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,600.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,804.00 Cr. (Mar 2025) to 1,600.00 Cr., marking a decrease of 204.00 Cr..
- For CWIP, as of Sep 2025, the value is 212.00 Cr.. The value appears strong and on an upward trend. It has increased from 188.00 Cr. (Mar 2025) to 212.00 Cr., marking an increase of 24.00 Cr..
- For Investments, as of Sep 2025, the value is 1,040.00 Cr.. The value appears strong and on an upward trend. It has increased from 583.00 Cr. (Mar 2025) to 1,040.00 Cr., marking an increase of 457.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,383.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,289.00 Cr. (Mar 2025) to 1,383.00 Cr., marking a decrease of 906.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,234.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,863.00 Cr. (Mar 2025) to 4,234.00 Cr., marking a decrease of 629.00 Cr..
Notably, the Reserves (3,209.00 Cr.) exceed the Borrowings (547.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -704.00 | -818.00 | 226.00 | 377.00 | -542.00 | 236.00 | 337.00 | -486.00 | -352.00 | -17.00 | 411.00 | 469.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 25 | 33 | 24 | 12 | 37 | 29 | 16 | 19 | 17 | 15 | 13 |
| Inventory Days | 252 | 310 | 476 | 367 | 161 | 284 | 345 | 274 | 213 | 163 | 329 | 222 |
| Days Payable | 113 | 133 | 125 | 62 | 92 | 109 | 102 | 54 | 43 | 33 | 71 | 27 |
| Cash Conversion Cycle | 144 | 202 | 384 | 329 | 81 | 212 | 272 | 237 | 188 | 147 | 273 | 208 |
| Working Capital Days | 16 | 4 | 50 | 34 | 20 | 82 | 45 | 64 | 67 | 81 | 45 | 98 |
| ROCE % | 6% | 5% | 8% | 17% | 9% | 11% | 12% | 14% | 14% | 12% | 10% | 9% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 20,605 | 0.17 | 0.95 | 20,605 | 2025-04-22 15:56:59 | 0% |
| Groww Nifty Total Market Index Fund | 52 | 0.01 | 0 | 52 | 2025-04-22 17:25:37 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 33.66 | 30.90 | 36.54 | 33.40 | 23.87 |
| Diluted EPS (Rs.) | 33.66 | 30.90 | 36.54 | 33.40 | 23.87 |
| Cash EPS (Rs.) | 49.34 | 45.87 | 48.23 | 45.20 | 30.93 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 362.22 | 334.15 | 291.42 | 264.69 | 187.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 362.22 | 334.15 | 291.42 | 264.69 | 187.62 |
| Revenue From Operations / Share (Rs.) | 358.17 | 401.74 | 372.85 | 331.76 | 260.75 |
| PBDIT / Share (Rs.) | 66.76 | 63.26 | 63.20 | 65.03 | 48.56 |
| PBIT / Share (Rs.) | 51.08 | 48.28 | 51.50 | 53.23 | 41.49 |
| PBT / Share (Rs.) | 44.89 | 43.63 | 47.20 | 45.58 | 30.57 |
| Net Profit / Share (Rs.) | 33.66 | 30.89 | 36.53 | 33.40 | 23.87 |
| NP After MI And SOA / Share (Rs.) | 33.66 | 30.89 | 36.53 | 33.40 | 23.87 |
| PBDIT Margin (%) | 18.64 | 15.74 | 16.95 | 19.60 | 18.62 |
| PBIT Margin (%) | 14.26 | 12.01 | 13.81 | 16.04 | 15.91 |
| PBT Margin (%) | 12.53 | 10.86 | 12.65 | 13.74 | 11.72 |
| Net Profit Margin (%) | 9.39 | 7.68 | 9.79 | 10.06 | 9.15 |
| NP After MI And SOA Margin (%) | 9.39 | 7.68 | 9.79 | 10.06 | 9.15 |
| Return on Networth / Equity (%) | 9.29 | 9.24 | 12.53 | 12.61 | 12.72 |
| Return on Capital Employeed (%) | 11.60 | 11.88 | 14.35 | 16.84 | 16.06 |
| Return On Assets (%) | 5.27 | 6.57 | 7.73 | 7.24 | 5.61 |
| Long Term Debt / Equity (X) | 0.11 | 0.12 | 0.14 | 0.10 | 0.27 |
| Total Debt / Equity (X) | 0.48 | 0.16 | 0.34 | 0.44 | 0.78 |
| Asset Turnover Ratio (%) | 0.64 | 0.85 | 0.80 | 0.75 | 0.62 |
| Current Ratio (X) | 1.55 | 2.73 | 2.08 | 1.73 | 1.43 |
| Quick Ratio (X) | 0.44 | 0.70 | 0.72 | 0.56 | 0.44 |
| Inventory Turnover Ratio (X) | 1.88 | 1.84 | 1.47 | 1.39 | 1.35 |
| Dividend Payout Ratio (NP) (%) | 14.11 | 12.94 | 16.41 | 0.00 | 18.18 |
| Dividend Payout Ratio (CP) (%) | 9.62 | 8.72 | 12.43 | 0.00 | 14.02 |
| Earning Retention Ratio (%) | 85.89 | 87.06 | 83.59 | 0.00 | 81.82 |
| Cash Earning Retention Ratio (%) | 90.38 | 91.28 | 87.57 | 0.00 | 85.98 |
| Interest Coverage Ratio (X) | 10.79 | 13.59 | 14.69 | 8.51 | 4.45 |
| Interest Coverage Ratio (Post Tax) (X) | 6.44 | 7.59 | 9.54 | 5.38 | 3.19 |
| Enterprise Value (Cr.) | 3651.88 | 3109.74 | 4615.19 | 2388.23 | 1521.35 |
| EV / Net Operating Revenue (X) | 1.26 | 0.95 | 1.53 | 0.88 | 0.72 |
| EV / EBITDA (X) | 6.76 | 6.07 | 9.02 | 4.54 | 3.87 |
| MarketCap / Net Operating Revenue (X) | 0.94 | 0.83 | 1.29 | 0.56 | 0.18 |
| Retention Ratios (%) | 85.88 | 87.05 | 83.58 | 0.00 | 81.81 |
| Price / BV (X) | 0.93 | 1.01 | 1.65 | 0.70 | 0.26 |
| Price / Net Operating Revenue (X) | 0.94 | 0.83 | 1.29 | 0.56 | 0.18 |
| EarningsYield | 0.09 | 0.09 | 0.07 | 0.17 | 0.48 |
After reviewing the key financial ratios for Dalmia Bharat Sugar & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 30.90 (Mar 23) to 33.66, marking an increase of 2.76.
- For Diluted EPS (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 30.90 (Mar 23) to 33.66, marking an increase of 2.76.
- For Cash EPS (Rs.), as of Mar 24, the value is 49.34. This value is within the healthy range. It has increased from 45.87 (Mar 23) to 49.34, marking an increase of 3.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 362.22. It has increased from 334.15 (Mar 23) to 362.22, marking an increase of 28.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 362.22. It has increased from 334.15 (Mar 23) to 362.22, marking an increase of 28.07.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 358.17. It has decreased from 401.74 (Mar 23) to 358.17, marking a decrease of 43.57.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 66.76. This value is within the healthy range. It has increased from 63.26 (Mar 23) to 66.76, marking an increase of 3.50.
- For PBIT / Share (Rs.), as of Mar 24, the value is 51.08. This value is within the healthy range. It has increased from 48.28 (Mar 23) to 51.08, marking an increase of 2.80.
- For PBT / Share (Rs.), as of Mar 24, the value is 44.89. This value is within the healthy range. It has increased from 43.63 (Mar 23) to 44.89, marking an increase of 1.26.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 30.89 (Mar 23) to 33.66, marking an increase of 2.77.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 30.89 (Mar 23) to 33.66, marking an increase of 2.77.
- For PBDIT Margin (%), as of Mar 24, the value is 18.64. This value is within the healthy range. It has increased from 15.74 (Mar 23) to 18.64, marking an increase of 2.90.
- For PBIT Margin (%), as of Mar 24, the value is 14.26. This value is within the healthy range. It has increased from 12.01 (Mar 23) to 14.26, marking an increase of 2.25.
- For PBT Margin (%), as of Mar 24, the value is 12.53. This value is within the healthy range. It has increased from 10.86 (Mar 23) to 12.53, marking an increase of 1.67.
- For Net Profit Margin (%), as of Mar 24, the value is 9.39. This value is within the healthy range. It has increased from 7.68 (Mar 23) to 9.39, marking an increase of 1.71.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.39. This value is within the healthy range. It has increased from 7.68 (Mar 23) to 9.39, marking an increase of 1.71.
- For Return on Networth / Equity (%), as of Mar 24, the value is 9.29. This value is below the healthy minimum of 15. It has increased from 9.24 (Mar 23) to 9.29, marking an increase of 0.05.
- For Return on Capital Employeed (%), as of Mar 24, the value is 11.60. This value is within the healthy range. It has decreased from 11.88 (Mar 23) to 11.60, marking a decrease of 0.28.
- For Return On Assets (%), as of Mar 24, the value is 5.27. This value is within the healthy range. It has decreased from 6.57 (Mar 23) to 5.27, marking a decrease of 1.30.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 23) to 0.11, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.48. This value is within the healthy range. It has increased from 0.16 (Mar 23) to 0.48, marking an increase of 0.32.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.64. It has decreased from 0.85 (Mar 23) to 0.64, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 24, the value is 1.55. This value is within the healthy range. It has decreased from 2.73 (Mar 23) to 1.55, marking a decrease of 1.18.
- For Quick Ratio (X), as of Mar 24, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 23) to 0.44, marking a decrease of 0.26.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 4. It has increased from 1.84 (Mar 23) to 1.88, marking an increase of 0.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 14.11. This value is below the healthy minimum of 20. It has increased from 12.94 (Mar 23) to 14.11, marking an increase of 1.17.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.62. This value is below the healthy minimum of 20. It has increased from 8.72 (Mar 23) to 9.62, marking an increase of 0.90.
- For Earning Retention Ratio (%), as of Mar 24, the value is 85.89. This value exceeds the healthy maximum of 70. It has decreased from 87.06 (Mar 23) to 85.89, marking a decrease of 1.17.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.38. This value exceeds the healthy maximum of 70. It has decreased from 91.28 (Mar 23) to 90.38, marking a decrease of 0.90.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 10.79. This value is within the healthy range. It has decreased from 13.59 (Mar 23) to 10.79, marking a decrease of 2.80.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.44. This value is within the healthy range. It has decreased from 7.59 (Mar 23) to 6.44, marking a decrease of 1.15.
- For Enterprise Value (Cr.), as of Mar 24, the value is 3,651.88. It has increased from 3,109.74 (Mar 23) to 3,651.88, marking an increase of 542.14.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.26. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.26, marking an increase of 0.31.
- For EV / EBITDA (X), as of Mar 24, the value is 6.76. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 6.76, marking an increase of 0.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.83 (Mar 23) to 0.94, marking an increase of 0.11.
- For Retention Ratios (%), as of Mar 24, the value is 85.88. This value exceeds the healthy maximum of 70. It has decreased from 87.05 (Mar 23) to 85.88, marking a decrease of 1.17.
- For Price / BV (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.01 (Mar 23) to 0.93, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.83 (Mar 23) to 0.94, marking an increase of 0.11.
- For EarningsYield, as of Mar 24, the value is 0.09. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dalmia Bharat Sugar & Industries Ltd:
- Net Profit Margin: 9.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.6% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.29% (Industry Average ROE: 7.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.49 (Industry average Stock P/E: 34.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | Dalmiapuram, Tiruchirapalli Dist. Tamil Nadu 621651 | sec.corp@dalmiasugar.com http://www.dalmiasugar.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajeev Bakshi | Chairman & Ind.Director |
| Mr. Gautam Dalmia | Managing Director |
| Mr. Pankaj Rastogi | WholeTime Director & CEO |
| Mr. Bharat Bhushan Mehta | Non Executive Director |
| Mr. Venkatesan Thyagarajan | Non Executive Director |
| Ms. Amita Misra | Independent Director |
| Mr. Neeraj Chandra | Independent Director |
FAQ
What is the intrinsic value of Dalmia Bharat Sugar & Industries Ltd?
Dalmia Bharat Sugar & Industries Ltd's intrinsic value (as of 16 December 2025) is 302.30 which is 0.56% lower the current market price of 304.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,459 Cr. market cap, FY2025-2026 high/low of 465/279, reserves of ₹3,209 Cr, and liabilities of 4,234 Cr.
What is the Market Cap of Dalmia Bharat Sugar & Industries Ltd?
The Market Cap of Dalmia Bharat Sugar & Industries Ltd is 2,459 Cr..
What is the current Stock Price of Dalmia Bharat Sugar & Industries Ltd as on 16 December 2025?
The current stock price of Dalmia Bharat Sugar & Industries Ltd as on 16 December 2025 is 304.
What is the High / Low of Dalmia Bharat Sugar & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dalmia Bharat Sugar & Industries Ltd stocks is 465/279.
What is the Stock P/E of Dalmia Bharat Sugar & Industries Ltd?
The Stock P/E of Dalmia Bharat Sugar & Industries Ltd is 7.49.
What is the Book Value of Dalmia Bharat Sugar & Industries Ltd?
The Book Value of Dalmia Bharat Sugar & Industries Ltd is 399.
What is the Dividend Yield of Dalmia Bharat Sugar & Industries Ltd?
The Dividend Yield of Dalmia Bharat Sugar & Industries Ltd is 1.97 %.
What is the ROCE of Dalmia Bharat Sugar & Industries Ltd?
The ROCE of Dalmia Bharat Sugar & Industries Ltd is 9.48 %.
What is the ROE of Dalmia Bharat Sugar & Industries Ltd?
The ROE of Dalmia Bharat Sugar & Industries Ltd is 12.4 %.
What is the Face Value of Dalmia Bharat Sugar & Industries Ltd?
The Face Value of Dalmia Bharat Sugar & Industries Ltd is 2.00.